trending Market Intelligence /marketintelligence/en/news-insights/trending/vh5Ypd-LnJlMt77l8Q7AfA2 content esgSubNav
In This List

Spark Therapeutics starts common stock offering

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Spark Therapeutics starts common stock offering

Spark Therapeutics Inc. initiated an underwritten public offering of $300 million of its common stock.

The company also intends to grant the underwriters an option to buy up to an additional 15% of the shares offered.

J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Cowen and Co. LLC will act as book-running managers for the offering.